UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$622M |
| 2 |
Mondelez International
MDLZ
|
+$579M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$418M |
| 4 |
Deutsche Bank
DB
|
+$340M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
NXP Semiconductors
NXPI
|
+$533M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$383M |
| 4 |
Hilton Worldwide
HLT
|
+$340M |
| 5 |
CERN
Cerner Corp
CERN
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.75% |
| 2 | Healthcare | 6.75% |
| 3 | Technology | 6.26% |
| 4 | Industrials | 5.06% |
| 5 | Consumer Discretionary | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBT
4601
Beacon Financial Corp
BBT
$2.67B
| $240K | ﹤0.01% |
6,821
-1,671
| -20% | -$60.1K |
|
4602
ProShares Ulta SmallCap600
SAA
$30.2M
| $239K | ﹤0.01% |
14,205
+4,470
| +46% | +$72.6K |
|
4603
VanEck Uranium + Nuclear Energy ETF
NLR
$4.04B
| $238K | ﹤0.01% |
4,732
-1,572
| -25% | -$79.2K |
|
4604
NMI Holdings
NMIH
$3.31B
| $238K | ﹤0.01% |
20,849
+1,249
| +6% | +$14K |
|
|
SCD
4605
LMP Capital and Income Fund
SCD
$360M
| $238K | ﹤0.01% |
16,761
+214
| +1% | +$3.06K |
|
|
TLND
4606
DELISTED
Talend S.A. American Depositary Shares
TLND
| $238K | ﹤0.01% |
6,845
-1,054
| -13% | -$34.4K |
|
|
HDP
4607
DELISTED
Hortonworks, Inc.
HDP
| $238K | ﹤0.01% |
18,434
-9,462
| -34% | -$113K |
|
4608
Invesco China Technology ETF
CQQQ
$3.17B
| $237K | ﹤0.01% |
5,076
+1,355
| +36% | +$60.7K |
|
4609
Capital City Bank Group
CCBG
$894M
| $236K | ﹤0.01% |
11,586
-458
| -4% | -$9.2K |
|
|
CLDT
4610
Chatham Lodging
CLDT
$607M
| $236K | ﹤0.01% |
11,732
-8,432
| -42% | -$166K |
|
4611
Ironwood Pharmaceuticals
IRWD
$701M
| $236K | ﹤0.01% |
14,930
+14,389
| +2,660% | +$209K |
|
4612
Westwood Holdings Group
WHG
$185M
| $236K | ﹤0.01% |
4,170
-830
| -17% | -$45.9K |
|
|
FSB
4613
DELISTED
Franklin Financial Network, Inc.
FSB
| $236K | ﹤0.01% |
5,719
+168
| +3% | +$6.76K |
|
4614
Atlantic Union Bankshares
AUB
$6.02B
| $235K | ﹤0.01% |
6,911
-106
| -2% | -$3.62K |
|
|
GLV
4615
Clough Global Dividend & Income Fund
GLV
$78.4M
| $235K | ﹤0.01% |
17,625
+5,450
| +45% | +$73.6K |
|
4616
Vanda Pharmaceuticals
VNDA
$308M
| $235K | ﹤0.01% |
14,438
+2,618
| +22% | +$37.7K |
|
|
SIRE
4617
DELISTED
Sisecam Resources LP
SIRE
| $235K | ﹤0.01% |
8,561
+2,159
| +34% | +$61K |
|
4618
OSI Systems
OSIS
$3.91B
| $234K | ﹤0.01% |
3,114
-682
| -18% | -$51.6K |
|
|
STML
4619
DELISTED
Stemline Therapeutics, Inc.
STML
| $234K | ﹤0.01% |
25,359
-1,586
| -6% | -$13.2K |
|
|
GUR
4620
DELISTED
SPDR S&P Emerging Europe ETF
GUR
| $233K | ﹤0.01% |
7,971
-33,638
| -81% | -$989K |
|
4621
ProShares UltraPro MidCap400
UMDD
$33.7M
| $232K | ﹤0.01% |
+12,905
| New | +$227K |
|
4622
8x8 Inc
EGHT
$327M
| $231K | ﹤0.01% |
15,829
-9,106
| -37% | -$129K |
|
4623
Southside Bancshares
SBSI
$974M
| $231K | ﹤0.01% |
6,608
+104
| +2% | +$3.49K |
|
|
FPRX
4624
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $231K | ﹤0.01% |
7,676
+1,604
| +26% | +$50.1K |
|
4625
Hope Bancorp
HOPE
$1.78B
| $230K | ﹤0.01% |
12,320
-1,410
| -10% | -$26.2K |
|
Similar funds
UBS Group's Q2 2017 Portfolio in Review
As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.
- UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
- UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
- UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
- UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
- UBS Group opened 756 new positions and closed 742 in Q2 2017.
- UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.
Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.